Tag Archives: WHO

UN Pact Scuttles Anti-Vaccine Provision

By Jill Wechsler | Published: January 24, 2013
A new international agreement to reduce mercury contamination of air and water was recently adopted by 140 countries, without a proposal that threatened to limit access to vaccines in much of the world. The credit goes to public health authorities and medical experts who challenged a provision blocking production of vaccines with the preservative thimerosal, [...]
Posted in Emerging Markets, FDA, Global, Legal, Market Access, Patient Communication, Safety, healthcare | Also tagged , , , , , | 1 Comment

Measuring Responsibility in Big Pharma

By Guest Blogger | Published: September 7, 2012
Measuring Responsibility in Big Pharma If you can’t measure it, the saying goes, it doesn’t count.  But what if you’re measuring the wrong things? The Access to Medicines Index (www.accesstomedicineindex.org) is an attempt to measure and compare the corporate social responsibility of both innovator (20) and generics (7) companies based on a number of different (and often [...]
Posted in Corporate Responsibility, Guest Blog, healthcare | Also tagged , , , , | Leave a comment

Will WHO Member States Pony Up for Neglected Diseases?

By Ben Comer | Published: May 21, 2012
Recognizing that traditional market forces – namely incentives related to intellectual property and a steady demand for products – have failed in developing countries, the World Health Organization (WHO) asked a member state-nominated group to come up with ways to fund R&D and pay for the treatment of neglected diseases in the world’s poorest nations. [...]
Posted in Emerging Markets, Global, IP, Legal, Manufacturing, Market Access, R&D, leadership, pricing | Also tagged , , , , , , , , , | Leave a comment

New Coalition Takes on Neglected Tropical Diseases

By Jennifer Ringler | Published: November 1, 2011
A new coalition for sharing pharma IP takes aim at the increasing burden of neglected tropical diseases in the developing world. According to the World Health Organization, neglected tropical diseases affect more than one billion of the world’s poorest 2.7 billion people. Many of these diseases, which can cause blindness and other debilitating symptoms, have reached [...]
Posted in Corporate Responsibility, IP | Also tagged , , , , | Leave a comment

Industry, Patents and Public Health: Wimps on the Barbie?

By William Looney | Published: October 20, 2010
The welcome news of a compact between industry and the WHO to fight neglected diseases in the developing world only highlights a much more spotty industry record of engagement on sensitive policy issues like intellectual property rights. One of the industry’s more ambitious policy-driven efforts occurred some five years ago with a strong, well-funded and broadly [...]
Posted in Corporate Responsibility, Global, Legal, R&D, Strategy | Also tagged , , , | 1 Comment